Earnings History Data for United Therapeutics Corporation (UTHR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

United Therapeutics Corporation

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
21-02-2024 PM UTHR United Therapeutics Corporation 10,090 4.36 3.92 2.67 United Therapeutics GAAP EPS of $4.36 beats by $0.17, revenue of $614.7M beats by $38.83M
[2/21/2024 6:02 AM]
219.30 5.14 
(2.40%)
205.06 -9.10 
(-4.25%)
204.44 - 261.54 531,296 350,000 0
01-11-2023 PM UTHR United Therapeutics Corporation 10,350 5.38 4.89 4.91 United Therapeutics GAAP EPS of $5.38 beats by $0.34, revenue of $609.4M beats by $23.58M
[11/1/2023 6:04 AM]
224.06 1.20 
(0.54%)
223.00 0.14 
(0.06%)
204.44 - 283.09 954,386 260,000 12,702
02-08-2023 PM UTHR United Therapeutics Corporation 11,370 5.24 4.41 2.41 United Therapeutics beats Q2 top and bottom line estimates
[8/2/2023 6:02 AM]
241.22 1.09 
(0.45%)
260.00 19.87 
(8.27%)
201.65 - 283.09 864,016 300,000 6,690
03-05-2023 PM 6:00 AM ET
(May 3)
UTHR United Therapeutics Corporation 10,750 4.86 4.26 5.03 United Therapeutics GAAP EPS of $4.86 beats by $0.36, revenue of $506.9M misses by $7.47M
[5/3/2023 6:05 AM]
218.89 -9.90 
(-4.33%)
0.0 0.0 
(0.00%)
174.36 - 283.09 802,283 390,000 0
22-02-2023 PM 6:00 AM ET
(Feb 22)
UTHR United Therapeutics Corporation 11,460 2.67 4.12 2.35 United Therapeutics GAAP EPS of $2.67 misses by $1.83, revenue of $491.5M misses by $27.7M
[2/22/2023 6:02 AM]
243.69 -11.56 
(-4.53%)
240.06 -15.19 
(-5.95%)
158.38 - 283.09 790,469 440,000 14,614
02-11-2022 PM 6:00 AM ET
(Nov 2)
UTHR United Therapeutics Corporation 10,490 4.91 3.57 3.42 United Therapeutics GAAP EPS of $4.91 beats by $1.10, revenue of $516M beats by $22.54M
[11/2/2022 6:02 AM]
254.21 25.82 
(11.31%)
228.39 0.0 
(0.00%)
158.38 - 259.18 1,561,719 290,000 3,676
03-08-2022 PM 6:00 AM ET
(Aug 3)
UTHR United Therapeutics Corporation 10,210 2.41 4.10 3.65 United Therapeutics GAAP EPS of $2.41 misses by $1.55, revenue of $466.9M beats by $5.84M
[8/3/2022 6:02 AM]
228.78 4.03 
(1.79%)
224.75 0.0 
(0.00%)
158.38 - 245.48 529,336 380,000 6,930
04-05-2022 PM 6:00 AM ET
(May 4)
UTHR United Therapeutics 8,014 5.03 2.96 0.00 United Therapeutics GAAP EPS of $5.03 beats by $1.96, revenue of $461.9M beats by $41.88M
[5/4/2022 6:03 AM]
185.53 5.85 
(3.26%)
179.68 0.0 
(0.00%)
158.38 - 218.38 567,334 340,000 7,578
24-02-2022 PM 6:00 AM ET
(Feb 24)
UTHR United Therapeutics Corporation 8,720 2.35 3.77 2.19 United Therapeutics Non-GAAP EPS of $3.51 misses by $0.54, revenue of $415.2M misses by $12.39M
[2/24/2022 6:03 AM]
168.04 -25.07 
(-12.98%)
0.0 0.0 
(0.00%)
155.71 - 218.38 1,358,771 392,411 0
03-11-2021 PM 6:00 AM ET
(Nov 3)
UTHR United Therapeutics Corporation 8,700 3.42 3.37 3.84 United Therapeutics EPS beats by $0.07, beats on revenue
[11/3/2021 6:13 AM]
203.27 11.08 
(5.76%)
193.00 0.80 
(0.42%)
129.43 - 216.90 750,728 450,000 4,320
04-08-2021 PM 6:00 AM ET
(Aug 4)
UTHR United Therapeutics Corporation 8,060 3.65 2.86 2.41 United Therapeutics EPS beats by $0.53, beats on revenue
[8/4/2021 6:03 AM]
206.09 25.43 
(14.08%)
206.09 0.0 
(0.00%)
98.37 - 212.62 1,589,541 220,000 5,734
05-05-2021 PM 6:00 AM ET
(May 5)
UTHR United Therapeutics Corporation 8,980 0.61 2.60 3.12 United Therapeutics EPS in-line, beats on revenue
[5/5/2021 6:01 AM]
198.14 2.77 
(1.42%)
198.14 0.0 
(0.00%)
98.37 - 212.62 406,467 250,000 4,439
24-02-2021 PM 6:00 AM ET
(Feb 24)
UTHR United Therapeutics Corporation 7,750 2.19 2.96 1.20 United Therapeutics EPS misses by $0.20, beats on revenue
[2/24/2021 6:06 AM]
173.90 1.52 
(0.88%)
172.38 0.0 
(0.00%)
75.58 - 181.14 380,203 284,896 4,751
28-10-2020 PM 6:00 AM ET
(Oct 28)
UTHR United Therapeutics Corporation 5,490 3.84 2.41 3.01 United Therapeutics EPS beats by $0.54, beats on revenue
[10/28/2020 6:04 AM]
132.09 8.69 
(7.04%)
123.40 0.0 
(0.00%)
75.58 - 132.99 1,085,972 574,028 9,489
29-07-2020 PM 6:00 AM ET
(Jul 29)
UTHR United Therapeutics Corporation 5,050 2.41 2.41 4.66 United Therapeutics EPS beats by $0.41, beats on revenue
[7/29/2020 6:05 AM]
113.11 -0.05 
(-0.04%)
116.00 2.84 
(2.51%)
75.58 - 127.79 322,315 343,051 2,542